Bigspas-D 25mg/25mg Injection
By Bigspas-D
Rx
2ml Injection in a Vial

Composition
Camylofin(25mg) + Diclofenac(25mg)

Manufacturer - Mankind Pharma Ltd
208, Okhla Industrial Estate, Phase III, New Delhi - 110020

Expires on or after
August, 2025

liver
Bigspas-D 25mg/25mg Injection needs caution when used in patients with liver disease. It might require adjusting the dose, so always consult your doctor before taking it. It is advised to regularly monitor liver function tests if you are using this medication for an extended period, especially if you have liver issues.

kidney
Bigspas-D 25mg/25mg Injection requires caution in patients with kidney disease due to possible need for dose adjustment. Consult your doctor.

alcohol
Caution is advised when consuming alcohol with Bigspas-D 25mg/25mg Injection. It is recommended to consult your doctor regarding alcohol intake.

driving
When taking Bigspas-D 25mg/25mg Injection, be cautious before driving as it may cause side effects like headaches, blurred vision, dizziness, or drowsiness, affecting your ability to drive.

pregnancy
Bigspas-D 25mg/25mg Injection is considered unsafe during pregnancy due to known risks to the developing baby. In rare life-threatening cases, a doctor may prescribe it if benefits outweigh risks. Consult your doctor for guidance.

breastfeeding
It is better to consult your doctor before using Bigspas-D 25mg/25mg Injection during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹18.12
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025